Skip to content
Trial Eligibility
Menu

Multisite Implementation of COMPRENDO

NCT06055296

This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .

Summary

COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting implementation. This study will test the impact of COMPRENDO, a peer-navigation intervention, vs. usual care on accrual to childhood cancer therapeutic clinical trials and parental informed consent outcomes. COMPRENDO will be delivered by trained peer navigators in 4 visits.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pediatric Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
University of California, San Diego
Last updated on ClinicalTrials.gov
June 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • Children's of Alabama/University of Alabama at Birmingham · Birmingham, AL

California · 2

  • Rady Children's Hospital San Diego/University of California San Diego Moores Cancer Center · San Diego, CA
  • University of California San Francisco Benioff Children's Hospitals · San Francisco, CA

Massachusetts · 1

  • Dana Farber Cancer Institute/Boston Children's Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.